ŞANLIOĞLU, S. Et Al. 2006. TRAIL-R4 (DcR2) receptor gene expression is correlated with high Gleason scores, PSA recurrence, and decreased survival in patients with prostate carcinoma. XIV Annual Congress of the European Society of Gene Therapy , (Atina, Greece), 141.

ŞANLIOĞLU, S., ŞANLIOĞLU, A. D., KARACAY, B., KÖKSAL, İ. T., & Griffith, T. S., (2006). TRAIL-R4 (DcR2) receptor gene expression is correlated with high Gleason scores, PSA recurrence, and decreased survival in patients with prostate carcinoma . XIV Annual Congress of the European Society of Gene Therapy (pp.141). Atina, Greece

ŞANLIOĞLU, SALİH Et Al. "TRAIL-R4 (DcR2) receptor gene expression is correlated with high Gleason scores, PSA recurrence, and decreased survival in patients with prostate carcinoma," XIV Annual Congress of the European Society of Gene Therapy, Atina, Greece, 2006

ŞANLIOĞLU, SALİH Et Al. "TRAIL-R4 (DcR2) receptor gene expression is correlated with high Gleason scores, PSA recurrence, and decreased survival in patients with prostate carcinoma." XIV Annual Congress of the European Society of Gene Therapy , Atina, Greece, pp.141, 2006

ŞANLIOĞLU, S. Et Al. (2006) . "TRAIL-R4 (DcR2) receptor gene expression is correlated with high Gleason scores, PSA recurrence, and decreased survival in patients with prostate carcinoma." XIV Annual Congress of the European Society of Gene Therapy , Atina, Greece, p.141.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={TRAIL-R4 (DcR2) receptor gene expression is correlated with high Gleason scores, PSA recurrence, and decreased survival in patients with prostate carcinoma}, congress name={XIV Annual Congress of the European Society of Gene Therapy}, city={Atina}, country={Greece}, year={2006}, pages={141} }